Import/Export & Cross-Border Compliance

In the pharmaceutical industry, time is more than money—it’s patient safety, product integrity, and regulatory trust. Yet, shipping delays remain a major operational threat. Based on a study of over 12,000 international pharma shipments, three key strategies consistently differentiate distributors who clear customs in under 72 hours from those facing repeated delays, spoilage, and added…

Why 73% of Pharma Shipments Get Stuck at Borders Every year, $2.1 billion worth of pharmaceutical products get held up at global customs checkpoints. What’s more shocking? 89% of these delays are caused by the same five preventable mistakes that trigger intensive inspections. This insider’s guide reveals the exact red flags customs officials look for…

Introduction: Tapping Into the $600 Billion US Pharma Market India supplies over 40% of generic drugs to the United States, playing a pivotal role in global healthcare. However, increasing regulatory scrutiny means that even minor documentation errors can lead to detained shipments, costly delays, or permanent import bans. This 2024 guide outlines the exact procedures…